Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (wegener's)

Arthritis Care and Research

Volumn 63, Issue 6, 2011, Pages 827-833

  Hajj Ali, Rula A ^a   Wilke, William S ^a   Calabrese, Leonard H ^a   Hoffman, Gary S ^a   Liu, Xiaobo ^a   Bena, James ^a   Clark, Tiffany ^a   Langford, Carol A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ADULT; AGED; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; BRIEF PATIENT HEALTH QUESTIONNAIRE 9; CLINICAL ASSESSMENT TOOL; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE ACTIVITY; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; LONDON FIBROMYALGIA EPIDEMIOLOGIC STUDY SCREENING QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PROSPECTIVE STUDY; QUALITATIVE RESEARCH; SLEEP DISORDER; SYMPTOM INTENSITY SCALE; VASCULITIS DAMAGE INDEX; VISUAL ANALOG SCALE; WEGENER GRANULOMATOSIS;

ADULT; AGED; DEPRESSION; FEMALE; FIBROMYALGIA; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PILOT PROJECTS; SLEEP DISORDERS; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 79958848311     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20442     Document Type: Article

References (23)

1. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Raspe HH, et al. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320-5. (Pubitemid 34627701)
2. Wilke WS. The clinical utility of fibromyalgia. J Clin Rheumatol 1999;5:97-102. (Pubitemid 29217870)
3. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32:1013-9. (Pubitemid 40828071)
4. Da Costa D, Bernatsky S, Dritsa M, Clarke AE, Dasgupta K, Keshani A, et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 2005;53: 272-8. (Pubitemid 40530169)
5. Creed F, Ash G. Depression in rheumatoid arthritis: etiology and treatment. Int Rev Psychiatry 1992;4:23-34.
6. White KP, Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 2003;30:1835-40. (Pubitemid 36962463)
7. Wolfe F, Rasker JJ. The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol 2006;33:2291-9. (Pubitemid 44749791)
8. Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006;54:169-76. (Pubitemid 43122199)
9. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16: 606-13. (Pubitemid 32823891)
10. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
11. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993;103:30-6. (Pubitemid 23027228)
12. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105. (Pubitemid 37432885)
14. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
15. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010;39:448-53.
16. Hauser W, Schmutzer G, Brahler E, Glaesmer H. A cluster within the continuum of biopsychosocial distress can be labeled "fibromyalgia syndrome": evidence from a representative German population survey. J Rheumatol 2009;36:2806-12.
17. Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse Disease Activity Score in 28 joints, Health Assessment Questionnaire, and Short Form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:794-800.
18. Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum 2009;61:667-73.
19. Buskila D, Press J, Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 2003;25:25-8. (Pubitemid 36819441)
20. Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003;49:826-37. (Pubitemid 37523636)
21. Raza K, Wilson A, Carruthers DM, Reay C, Amft N, Bacon PA. Impaired SF36 in patients with primary systemic necrotizing vasculitis (1°SNV): influence of factors besides disease activity and damage [abstract]. Arthritis Rheum 1999;42 Suppl: S315.
22. Wilke WS. New developments in the diagnosis of fibromyalgia syndrome: say goodbye to tender points? Cleve Clin J Med 2009;76:345-52.
23. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370: 851-8. (Pubitemid 47362344)